ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Internal Medicine

Top Internal Medicine Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARMELLA COLE MD

Internal Medicine

4,350

$394K

279
164 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $77

ROBERT JAYES M.D.

Internal Medicine

4,342

$225K

121
110 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

KEVIN GRIFFITHS MD

Internal Medicine

4,318

$558K

220
121 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$129
Average prescription price

Avg: $77

THOMAS TESORIERO MD

Internal Medicine

4,301

$234K

308
279 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $77

DANA MCGINTY MD

Internal Medicine

4,147

$339K

124
93 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $77

ELIZABETH BLUHM M.D.

Internal Medicine

4,075

$309K

354
211 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$76
Average prescription price

Avg: $77

FERDINAND CHUA MD

Internal Medicine

4,064

$242K

134
110 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

MARC SHEPARD M.D.

Internal Medicine

3,922

$277K

166
145 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $77

FRANCISCO KING M.D.

Internal Medicine

3,807

$293K

203
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $77

MATTY MATHIVANNAN MD

Internal Medicine

3,798

$1.57M

157
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 29%

$414
Average prescription price

Avg: $77

DEBORAH TOPOL MD

Internal Medicine

3,503

$258K

329
199 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $77

DOUGLAS VANZOEREN MD

Internal Medicine

3,468

$169K

316
291 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $77

KYLE ANDERS M.D.

Internal Medicine

3,441

$207K

212
120 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

EDGER POTTER MD

Internal Medicine

3,313

$217K

79
64 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

MAURICE WRIGHT

Internal Medicine

3,295

$260K

238
199 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $77

ROBERT BLEE MD

Internal Medicine

3,239

$287K

157
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $77

TEMKETEM TSIGE M.D.

Internal Medicine

3,206

$168K

247
213 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

DEBRA WHITE-COLEMAN MD

Internal Medicine

3,199

$212K

123
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $77

CHRISTOPHER MCMACKIN MD

Internal Medicine

3,147

$934K

85
50 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 29%

$297
Average prescription price

Avg: $77

TAMRAT RETTA MD

Internal Medicine

3,109

$131K

151
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$42
Average prescription price

Avg: $77

SILVIA PICCIAFUOCO MD

Internal Medicine

3,060

$135K

274
247 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$44
Average prescription price

Avg: $77

ANDREW LEE M.D.

Internal Medicine

2,979

$213K

208
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $77

SHIBAN RAINA MD

Internal Medicine

2,951

$124K

199
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$42
Average prescription price

Avg: $77

RUMANA SHAMEEM M.D.

Internal Medicine

2,948

$135K

277
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$46
Average prescription price

Avg: $77

SAULIUS NAUJOKAITIS M.D.

Internal Medicine

2,905

$181K

149
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank